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Abstract 
Dietary salt intake and hypertension are associated with increased risk of cardiovascular disease including stroke. We aimed to explore the influence of these factors, together with plasma sodium concentration, in cerebral small vessel disease. 264 patients with non-disabling cortical or lacunar stroke were recruited. Patients were questioned about their salt intake and plasma sodium concentration was measured; brain tissue volume and white matter hyperintensity load were measured using structural MRI while diffusion tensor MRI and dynamic contrast-enhanced MRI were acquired to assess underlying tissue integrity. An index of added salt intake (p=0.021), pulse pressure (p=0.036) and diagnosis of hypertension (p=0.0093) were positively associated with increased white matter hyperintensity volume, while plasma sodium concentration was associated with brain volume (p=0.019) but not with white matter hyperintensity volume. These results are consistent with previous findings that raised blood pressure is associated with white matter hyperintensity burden and raise the possibility of an independent role for dietary salt in the development of cerebral small vessel disease.
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Introduction
Cerebral small vessel disease (SVD) accounts for 20-25% of strokes and causes cognitive impairment, disability and dementia. The pathogenesis of SVD is poorly understood but hypertension and other vascular risk factors have been identified. Previous work in our group revealed associations between blood pressure and white matter hyperintensity (WMH) burden and between blood pressure and pre-visible white matter damage assessed by diffusion tensor imaging. ADDIN EN.CITE ,  
The influence of dietary salt intake on stroke incidence and mortality is well-known ADDIN EN.CITE 3 but may be only partly mediated by its effect on blood pressure. HYPERLINK \l "_ENREF_4" \o "Strazzullo, 2009 #4"  ADDIN EN.CITE <EndNote><Cite><Author>Strazzullo</Author><Year>2009</Year><RecNum>4</RecNum><DisplayText><style face="superscript">4</style></DisplayText><record><rec-number>4</rec-number><foreign-keys><key app="EN" db-id="tf0fsv95t5tvw8eefx35t2d8as2wtfwp20ts" timestamp="1425399761">4</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Strazzullo, P.</author><author>D&apos;Elia, L.</author><author>Kandala, N. B.</author><author>Cappuccio, F. P.</author></authors></contributors><auth-address>Department of Clinical and Experimental Medicine, Federico II University of Naples Medical School, Naples, Italy. strazzul@unina.it</auth-address><titles><title>Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies</title><secondary-title>Brit Med J</secondary-title><alt-title>Brit Med J</alt-title></titles><periodical><full-title>Brit Med J</full-title><abbr-1>Brit Med J</abbr-1></periodical><alt-periodical><full-title>Brit Med J</full-title><abbr-1>Brit Med J</abbr-1></alt-periodical><pages>b4567</pages><volume>339</volume><keywords><keyword>Adult</keyword><keyword>Aged</keyword><keyword>Blood Pressure/physiology</keyword><keyword>Body Mass Index</keyword><keyword>Cardiovascular Diseases/*etiology/physiopathology</keyword><keyword>Dose-Response Relationship, Drug</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Hypertension/etiology/physiopathology</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Prospective Studies</keyword><keyword>Sodium, Dietary/administration &amp; dosage/*adverse effects</keyword><keyword>Stroke/etiology/physiopathology</keyword></keywords><dates><year>2009</year></dates><isbn>1756-1833 (Electronic)&#xD;0959-535X (Linking)</isbn><accession-num>19934192</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/19934192</url></related-urls></urls><custom2>2782060</custom2><electronic-resource-num>10.1136/bmj.b4567</electronic-resource-num></record></Cite></EndNote>4 Plasma sodium concentration is assumed to be tightly regulated but there is some evidence to suggest that even small variations can affect physical and mental health in the elderly population. ADDIN EN.CITE ,  The role of dietary and plasma sodium in cerebral small vessel disease is unclear.
In this work we assessed a cohort of patients with recent non-disabling stroke and exhibiting a spectrum of small vessel disease severity. We performed magnetic resonance imaging (MRI) scans to assess white matter hyperintensity volume, brain tissue volume, diffusion tensor MRI (DT-MRI) measures of tissue integrity and T1-weighted imaging of contrast uptake. Blood pressure, an index of added dietary salt intake and plasma sodium concentration were assessed and tested for associations with imaging findings.



Materials and Methods
Participants
Participants were 264 adult patients who presented to our in- and out-patient stroke service. We recruited consecutive patients with first clinically evident non-disabling lacunar or mild cortical ischaemic stroke, including those with diabetes, hypertension and other vascular risk factors. We excluded patients with unstable hypertension or diabetes, other neurological disorders and major medical conditions including renal failure that would preclude use of intravenous gadolinium contrast agents. We excluded patients unable to give consent, with contraindications to MRI or intravenous contrast, who had haemorrhagic stroke or those whose symptoms resolved within 24 hours (i.e. transient ischaemic attack (TIA)). The study was approved by the Lothian Ethics of Medical Research Committee (REC 09/81101/54) and the NHS Lothian R+D Office (2009/W/NEU/14) and conducted according to the principles expressed in the Declaration of Helsinki. All patients gave written informed consent.
Clinical data, diet and smoking history, WMH volume, brain tissue volume and DT-MRI were obtained at presentation. Participants returned approximately one to three months after presentation for dynamic contrast-enhanced MRI (DCE-MRI), the delay being to avoid acute effects of the stroke on the local blood-brain barrier.
Clinical and laboratory measurements
On presentation, a clinician trained in stroke obtained the clinical details of the presenting stroke and determined the clinical stroke subtype (lacunar, cortical) using the Oxfordshire Community Stroke Project (OCSP) classification HYPERLINK \l "_ENREF_7" \o "Bamford, 1991 #7"  ADDIN EN.CITE <EndNote><Cite><Author>Bamford</Author><Year>1991</Year><RecNum>20</RecNum><DisplayText><style face="superscript">7</style></DisplayText><record><rec-number>7</rec-number><foreign-keys><key app="EN" db-id="tf0fsv95t5tvw8eefx35t2d8as2wtfwp20ts" timestamp="1425399762">7</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bamford, J.</author><author>Sandercock, P.</author><author>Dennis, M.</author><author>Burn, J.</author><author>Warlow, C.</author></authors></contributors><auth-address>Department of Neurology, St James&apos;s University Hospital, Leeds, UK.</auth-address><titles><title>Classification and natural history of clinically identifiable subtypes of cerebral infarction</title><secondary-title>Lancet</secondary-title><alt-title>Lancet</alt-title></titles><periodical><full-title>Lancet</full-title><abbr-1>Lancet</abbr-1></periodical><alt-periodical><full-title>Lancet</full-title><abbr-1>Lancet</abbr-1></alt-periodical><pages>1521-6</pages><volume>337</volume><number>8756</number><keywords><keyword>Age Factors</keyword><keyword>Aged</keyword><keyword>Cerebral Infarction/*classification/epidemiology/mortality/pathology</keyword><keyword>Female</keyword><keyword>Follow-Up Studies</keyword><keyword>Great Britain/epidemiology</keyword><keyword>Humans</keyword><keyword>Incidence</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Prospective Studies</keyword><keyword>Recurrence</keyword><keyword>Risk Factors</keyword></keywords><dates><year>1991</year><pub-dates><date>Jun 22</date></pub-dates></dates><isbn>0140-6736 (Print)&#xD;0140-6736 (Linking)</isbn><accession-num>1675378</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/1675378</url></related-urls></urls></record></Cite></EndNote>7. The same clinical researcher also recorded age, demographic details, past medical history of hypertension, previous stroke, previous TIA, ischaemic heart disease, peripheral vascular disease, diabetes mellitus, atrial fibrillation, hypercholesterolaemia, heart failure, smoking and alcohol use, as well as all medications used and obtained blood biochemistry, brain MR imaging and other stroke investigations. We defined hypertension as blood pressure of 140/90 mmHg or greater on presentation or a previous diagnosis; smokers were defined as currently smoking or having given up within the previous 12 months and non-smokers as having never smoked or having given up more than 12 months previously.
An experienced neuroradiologist assessed acute stroke subtype (lacunar or cortical) on MR diffusion-weighted imaging (generated from DT-MRI), FLAIR, T2 and T1-weighted diagnostic imaging. Acute lacunar infarcts were required to be less than 20 mm in maximum axial diameter and in the deep white or grey matter (GM) of the cerebral hemispheres or brainstem. Infarcts involving the cortex, or subcortical infarcts larger than 20 mm diameter (i.e. a large striatocapsular infarct) were classed as 'cortical' and due to the large artery atherothromboembolic aetiology. All scans and clinical details were then reviewed by an expert panel of neurologists, stroke physicians and neuroradiologists to establish the final stroke subtype using all clinical and imaging information. If no lesion was present on imaging, the stroke was classified based on the clinical findings alone using the Bamford classification. HYPERLINK \l "_ENREF_7" \o "Bamford, 1991 #7"  ADDIN EN.CITE <EndNote><Cite><Author>Bamford</Author><Year>1991</Year><RecNum>20</RecNum><DisplayText><style face="superscript">7</style></DisplayText><record><rec-number>7</rec-number><foreign-keys><key app="EN" db-id="tf0fsv95t5tvw8eefx35t2d8as2wtfwp20ts" timestamp="1425399762">7</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bamford, J.</author><author>Sandercock, P.</author><author>Dennis, M.</author><author>Burn, J.</author><author>Warlow, C.</author></authors></contributors><auth-address>Department of Neurology, St James&apos;s University Hospital, Leeds, UK.</auth-address><titles><title>Classification and natural history of clinically identifiable subtypes of cerebral infarction</title><secondary-title>Lancet</secondary-title><alt-title>Lancet</alt-title></titles><periodical><full-title>Lancet</full-title><abbr-1>Lancet</abbr-1></periodical><alt-periodical><full-title>Lancet</full-title><abbr-1>Lancet</abbr-1></alt-periodical><pages>1521-6</pages><volume>337</volume><number>8756</number><keywords><keyword>Age Factors</keyword><keyword>Aged</keyword><keyword>Cerebral Infarction/*classification/epidemiology/mortality/pathology</keyword><keyword>Female</keyword><keyword>Follow-Up Studies</keyword><keyword>Great Britain/epidemiology</keyword><keyword>Humans</keyword><keyword>Incidence</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Prospective Studies</keyword><keyword>Recurrence</keyword><keyword>Risk Factors</keyword></keywords><dates><year>1991</year><pub-dates><date>Jun 22</date></pub-dates></dates><isbn>0140-6736 (Print)&#xD;0140-6736 (Linking)</isbn><accession-num>1675378</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/1675378</url></related-urls></urls></record></Cite></EndNote>7
We measured systolic and diastolic blood pressure (SBP and DBP, respectively) from the brachial artery in the stroke clinic or stroke ward using hospital blood pressure devices, which were checked and maintained by technical staff. Pulse pressure (PP) and mean arterial pressure (MAP) were calculated as SBP-DBP and ⅓ SBP + ⅔ DBP respectively. Plasma sodium concentration was measured from blood samples taken during clinic assessment and measured in the NHS Lothian Biochemistry Department.

Participants were also asked to describe their addition of salt to food during cooking and at the dining table using the following salt intake score: 1=always, 2=often, 3=occasionally, 4=rarely, 5=never; the mean of the two scores was subtracted from 6 to give an ordinal categorical variable in the range 1 (minimum use of salt) to 5 (maximum use of salt) for use in statistical analyses.

Magnetic resonance imaging
Magnetic resonance imaging was performed with a 1.5 Tesla MRI scanner (Signa HDxt, General Electric, Milwaukee, WI) using an 8-channel phased-array head coil. Diagnostic MRI was acquired at presentation, including axial T2-weighted (T2W; TR/TE=6000/90 ms, 24x24 cm field of view (FoV), 384x384 Propeller acquisition, 1.5 averages, 28 x 5 mm slices, 1 mm slice gap), axial fluid-attenuated inversion recovery (FLAIR; TR/TE/TI=9000/153/2200, 24x24 cm FoV, 384×224 acquisition matrix, 28 x 5 mm slices, 1 mm slice gap), gradient echo (GRE; TR/TE=800/15 ms, 20° flip angle, 24x18 cm FoV, 384×168 acquisition matrix, 2 averages, 28 x 5 mm slices, 1 mm slice gap) and sagittal 3D T1-weighted imaging (T1W; inversion recovery-prepared spoiled gradient echo (SPGR) TR/TE/TI=7.3/2.9/500 ms, 8° flip angle, 330x214.5 cm FoV, 256×146 acquisition matrix, 100 x 1.8 mm slices) and DT-MRI (single-shot echo-planar imaging with 30 diffusion directions (b=1000 s/mm2) and 2 x b0 acquisitions, TR/TE=7700/82 ms, 24x24 cm FoV, 128x128 acquisition matrix, 28 x 5 mm slices, 1 mm slice gap). DCE-MRI was performed between one and three months after first presentation (median 38, interquartile range [31,54] days) and consisted of 20 consecutive 3D T1W SPGR acquisitions (TR/TE=8.2/3.1 ms, 12° flip angle, 24x24 cm FOV, 256x192 acquisition matrix, 42 x 4 mm slices, 73 s acquisition time) with a total acquisition time of approximately 24 minutes, initiated simultaneously with an intravenous bolus injection of 0.1 mmol/kg gadoterate meglumine (Gd-DOTA, Dotarem, Guerbet, France). Two additional SPGR acquisitions were obtained prior to contrast administration with flip angles of 2° and 12° respectively for calculation of the pre-contrast longitudinal relaxation time T1,0.
Image Processing and Analysis
Pre-processing: MR images were converted from DICOM to Analyze 7.5 format. Structural and DCE-MRI images were aligned to the pre-contrast T1W image using rigid-body registration (FSL-FLIRT HYPERLINK \l "_ENREF_8" \o "Jenkinson, 2002 #8"  ADDIN EN.CITE <EndNote><Cite><Author>Jenkinson</Author><Year>2002</Year><RecNum>11</RecNum><DisplayText><style face="superscript">8</style></DisplayText><record><rec-number>8</rec-number><foreign-keys><key app="EN" db-id="tf0fsv95t5tvw8eefx35t2d8as2wtfwp20ts" timestamp="1425399763">8</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Jenkinson, M.</author><author>Bannister, P.</author><author>Brady, M.</author><author>Smith, S.</author></authors></contributors><auth-address>Oxford Centre for Functional Magnetic Resonance Imaging of the Brain, John Radcliffe Hospital, Headington, United Kingdom.</auth-address><titles><title>Improved optimization for the robust and accurate linear registration and motion correction of brain images</title><secondary-title>Neuroimage</secondary-title><alt-title>NeuroImage</alt-title></titles><periodical><full-title>Neuroimage</full-title><abbr-1>NeuroImage</abbr-1></periodical><alt-periodical><full-title>Neuroimage</full-title><abbr-1>NeuroImage</abbr-1></alt-periodical><pages>825-41</pages><volume>17</volume><number>2</number><keywords><keyword>Acoustic Stimulation</keyword><keyword>Algorithms</keyword><keyword>Brain/*physiology</keyword><keyword>Computer Simulation</keyword><keyword>Data Interpretation, Statistical</keyword><keyword>Fuzzy Logic</keyword><keyword>Humans</keyword><keyword>Image Interpretation, Computer-Assisted/*methods</keyword><keyword>Linear Models</keyword><keyword>Models, Neurological</keyword><keyword>Motion</keyword><keyword>Photic Stimulation</keyword><keyword>Reproducibility of Results</keyword></keywords><dates><year>2002</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1053-8119 (Print)&#xD;1053-8119 (Linking)</isbn><accession-num>12377157</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/12377157</url></related-urls></urls></record></Cite></EndNote>8); for participants that did not receive DCE-MRI, images were instead co-registered to the T2W image.
Tissue segmentation: FLAIR and GRE images were processed using in-house software (“MCMxxxVI”  ADDIN EN.CITE 9) to extract WMH in the brain parenchyma; these were manually refined and, separately, old stroke lesions or index stroke lesions were manually outlined using Analyze 11.0 (AnalyzeDirect, KS). WMH were identified as punctate or diffuse areas in the white matter and deep GM of the cerebral hemispheres or in the brainstem that were 3 mm or larger in diameter and hyperintense with respect to normal-appearing white and grey matter on T2W and FLAIR images; some hypointensity on T1W MRI was allowed as long as not less intense than cerebrospinal fluid (CSF). WMH included “dirty” or ill-defined diffuse hyperintensities with varying and erratic intensity patterns emerging from the lateral ventricle wall ADDIN EN.CITE ,  provided such regions had outstanding intensity differences with respect to the normal-appearing white matter (NAWM) identified on T1W images. Index stroke lesions were defined as the hyperintense regions identified on the diffusion weighted image generated from the DT-MRI scan including any corresponding signal changes on FLAIR, T2W and T1W images, associated with swelling or lack of ex vacuo effect, that followed a vascular territory. Old stroke lesions were wedge-shaped hyperintense regions on the FLAIR or T2W image, and hypointense on the T1W image including cortex and/or subcortical tissues, with or without cavitation, and with ex vacuo effect reflecting tissue loss. NAWM masks were generated using MCMxxxVI as described in ADDIN EN.CITE 12. Subcortical GM masks were generated automatically by a software pipeline that used FSL-SUSAN HYPERLINK \l "_ENREF_13" \o "Smith, 1997 #13"  ADDIN EN.CITE <EndNote><Cite><Author>Smith</Author><Year>1997</Year><RecNum>17</RecNum><DisplayText><style face="superscript">13</style></DisplayText><record><rec-number>13</rec-number><foreign-keys><key app="EN" db-id="tf0fsv95t5tvw8eefx35t2d8as2wtfwp20ts" timestamp="1425399764">13</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Smith, S. M.</author><author>Brady, J. M.</author></authors></contributors><auth-address>Smith, SM&#xD;Univ Oxford,Dept Clin Neurol,Oxford,England&#xD;Univ Oxford,Dept Clin Neurol,Oxford,England&#xD;Univ Oxford,Dept Engn Sci,Oxford Ox1 3pj,England&#xD;Dra Chertsey,Lsi,Chertsey,Surrey,England</auth-address><titles><title>SUSAN - A new approach to low level image processing</title><secondary-title>Int J Comput Vision</secondary-title><alt-title>Int J Comput Vision</alt-title></titles><periodical><full-title>Int J Comput Vision</full-title><abbr-1>Int J Comput Vision</abbr-1></periodical><alt-periodical><full-title>Int J Comput Vision</full-title><abbr-1>Int J Comput Vision</abbr-1></alt-periodical><pages>45-78</pages><volume>23</volume><number>1</number><keywords><keyword>corner detection</keyword><keyword>edge-detection</keyword><keyword>enhancement</keyword><keyword>sequences</keyword><keyword>operator</keyword><keyword>filters</keyword></keywords><dates><year>1997</year><pub-dates><date>May</date></pub-dates></dates><isbn>0920-5691</isbn><accession-num>WOS:A1997XK55900003</accession-num><urls><related-urls><url>&lt;Go to ISI&gt;://WOS:A1997XK55900003</url></related-urls></urls><electronic-resource-num>Doi 10.1023/A:1007963824710</electronic-resource-num><language>English</language></record></Cite></EndNote>13 for noise reduction, an age-relevant brain template, ADDIN EN.CITE 14 FSL-FLIRT for aligning the template to each image dataset, and FSL-FIRST ADDIN EN.CITE 15 for extracting the subcortical structures, followed by manual boundary correction. To minimise any residual contamination of the subcortical GM, the mask was eroded by one voxel. An example of MR images and segmentation masks is shown in Figure 2.
Brain tissue volume: Intracranial volume (ICV), defined as contents within the inner skull table including brain tissue, CSF, veins and dura, and limited inferiorly by the tip of the odontoid peg at the foramen magnum, was extracted using the GRE image and the Object Extraction Tool in Analyze 11.0, followed by manual editing. Non-brain tissue (CSF, venous sinuses and meninges) were extracted using MCMxxxVI. The volume of the resulting “non-brain” binary masks was subtracted from the ICV to provide a measure of total brain tissue volume. For statistical analysis, the brain tissue volume as a percentage of ICV (%BTV) and WMH volume as a percentage of ICV (%WMH) were also calculated.
DT-MRI processing: DTI images were processed using in-house software, which removed bulk motion and eddy current induced distortions using FSL FLIRT HYPERLINK \l "_ENREF_8" \o "Jenkinson, 2002 #8"  ADDIN EN.CITE <EndNote><Cite><Author>Jenkinson</Author><Year>2002</Year><RecNum>11</RecNum><DisplayText><style face="superscript">8</style></DisplayText><record><rec-number>8</rec-number><foreign-keys><key app="EN" db-id="tf0fsv95t5tvw8eefx35t2d8as2wtfwp20ts" timestamp="1425399763">8</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Jenkinson, M.</author><author>Bannister, P.</author><author>Brady, M.</author><author>Smith, S.</author></authors></contributors><auth-address>Oxford Centre for Functional Magnetic Resonance Imaging of the Brain, John Radcliffe Hospital, Headington, United Kingdom.</auth-address><titles><title>Improved optimization for the robust and accurate linear registration and motion correction of brain images</title><secondary-title>Neuroimage</secondary-title><alt-title>NeuroImage</alt-title></titles><periodical><full-title>Neuroimage</full-title><abbr-1>NeuroImage</abbr-1></periodical><alt-periodical><full-title>Neuroimage</full-title><abbr-1>NeuroImage</abbr-1></alt-periodical><pages>825-41</pages><volume>17</volume><number>2</number><keywords><keyword>Acoustic Stimulation</keyword><keyword>Algorithms</keyword><keyword>Brain/*physiology</keyword><keyword>Computer Simulation</keyword><keyword>Data Interpretation, Statistical</keyword><keyword>Fuzzy Logic</keyword><keyword>Humans</keyword><keyword>Image Interpretation, Computer-Assisted/*methods</keyword><keyword>Linear Models</keyword><keyword>Models, Neurological</keyword><keyword>Motion</keyword><keyword>Photic Stimulation</keyword><keyword>Reproducibility of Results</keyword></keywords><dates><year>2002</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1053-8119 (Print)&#xD;1053-8119 (Linking)</isbn><accession-num>12377157</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/12377157</url></related-urls></urls></record></Cite></EndNote>8 and generated a directionally averaged diffusion weighted image, mean diffusivity (MD) and fractional anisotropy (FA) parametric images using standard methods based on multivariate linear regression. For each dataset nonlinear registration HYPERLINK \l "_ENREF_16" \o "Modat, 2010 #16"  ADDIN EN.CITE <EndNote><Cite><Author>Modat</Author><Year>2010</Year><RecNum>19</RecNum><DisplayText><style face="superscript">16</style></DisplayText><record><rec-number>16</rec-number><foreign-keys><key app="EN" db-id="tf0fsv95t5tvw8eefx35t2d8as2wtfwp20ts" timestamp="1425399766">16</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Modat, M.</author><author>Ridgway, G. R.</author><author>Taylor, Z. A.</author><author>Lehmann, M.</author><author>Barnes, J.</author><author>Hawkes, D. J.</author><author>Fox, N. C.</author><author>Ourselin, S.</author></authors></contributors><auth-address>Modat, M&#xD;UCL, Dept Med Phys &amp; Bioengn, Ctr Med Image Comp, London WC1N 3BG, England&#xD;UCL, Dept Med Phys &amp; Bioengn, Ctr Med Image Comp, London WC1N 3BG, England&#xD;UCL, Dept Med Phys &amp; Bioengn, Ctr Med Image Comp, London WC1N 3BG, England&#xD;UCL, UCL Inst Neurol, Dementia Res Ctr, London WC1N 3BG, England</auth-address><titles><title>Fast free-form deformation using graphics processing units</title><secondary-title>Comput Meth Prog Bio</secondary-title><alt-title>Comput Meth Prog Bio</alt-title></titles><periodical><full-title>Comput Meth Prog Bio</full-title><abbr-1>Comput Meth Prog Bio</abbr-1></periodical><alt-periodical><full-title>Comput Meth Prog Bio</full-title><abbr-1>Comput Meth Prog Bio</abbr-1></alt-periodical><pages>278-284</pages><volume>98</volume><number>3</number><keywords><keyword>gpu</keyword><keyword>non-rigid registration</keyword><keyword>free-form deformation</keyword><keyword>normalised mutual information</keyword><keyword>image registration</keyword><keyword>optimization</keyword></keywords><dates><year>2010</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>0169-2607</isbn><accession-num>WOS:000278631500008</accession-num><urls><related-urls><url>&lt;Go to ISI&gt;://WOS:000278631500008</url></related-urls></urls><electronic-resource-num>DOI 10.1016/j.cmpb.2009.09.002</electronic-resource-num><language>English</language></record></Cite></EndNote>16 was used to align the tissue masks in the structural space (T2W) with the parametric maps in the diffusion space using the NiftyReg tool (http://sourceforge.net/projects/niftyreg/ (​http:​/​​/​sourceforge.net​/​projects​/​niftyreg​/​​)) applied using TractoR software (http://www.tractor-mri.org.uk/diffusion-processing (​http:​/​​/​www.tractor-mri.org.uk​/​diffusion-processing​)) to obtain the transformation between the brain extracted structural T2W image and the b0 diffusion volume. To avoid partial volume averaging with CSF due to registration inaccuracies, the CSF mask was dilated by one voxel in each direction and then subtracted from the NAWM, WMH and subcortical GM masks in the diffusion space. Median MD and FA were extracted for NAWM and subcortical GM in each patient.
DCE-MRI: Median signal intensities for normal-appearing subcortical grey and white matter masks were extracted from the co-registered pre- and post-contrast T1W images. A vascular input function was also determined by manual selection of a voxel in the superior sagittal sinus, using a slice proximal to the basal ganglia structures and the lateral ventricles. This voxel was chosen to provide a high peak signal enhancement and smooth variation during the DCE-MRI time course and was chosen independently by two observers; where the observers selected different voxels, the voxel with the highest peak enhancement was chosen unless the signal curve was significantly noisier (a noise estimate was calculated as the sum of squared differences between the signal curve and a fitted bi-exponential curve). T1,0 was calculated using the median signal intensities in the two pre-contrast images with flip angles 2° and 12° and used to derive time-concentration curves for each tissue as described in  ADDIN EN.CITE 17; contrast agent concentration in the sagittal sinus was converted to plasma concentration using the factor 1/(1-Hct) and the most recent available haematocrit measurement in the patient’s clinical record (if no haematocrit measurement was available (n=3) we assumed Hct=0.45). To semi-quantitatively assess contrast uptake in tissue, we calculated the normalised area under curve (nAUC) defined as the area under the tissue concentration curve divided by the area under the superior sagittal sinus plasma concentration curve.

Statistical Analysis
Descriptive statistics in the text are given as mean ± standard deviation. Regressions were assessed by examination of the differences between the data and model predictions, and collinearity by variance inflation factors using SPSS version 19 (IBM Corp., NY, USA) and Matlab (MathWorks, Inc., MA, USA). Predictors of %WMH and %BTV were investigated using multiple linear regression models with correction for age, smoking status, stroke subtype and additional factors given in the text and tables. Residuals for the %WMH model were not approximately normally distributed; to correct for this, the transformed outcome variable ln(0.005+%WMH) was regressed instead. Subcortical GM MD (units 10-6 mm2s-1) was also transformed to ln(-700+MD) for this reason.


Results
Subjects
A total of 264 subjects were recruited into the study with mean age 66.9±11.8 years and a ratio of 45:55 for diagnosis of lacunar-to-cortical stroke; 39% of patients were smokers and 72% had hypertension (Table 1). Reasons for exclusion are shown in Figure 1. Following withdrawals and rejection of imaging data on quality grounds, DT-MRI and DCE-MRI data suitable for analysis were obtained in 262 and 201 patients respectively.
WMH and Brain Tissue Volume
Mean WMH volume as a percentage of ICV was 1.5±1.6% with a positively skewed distribution. Pulse pressure (β=0.0092 mmHg-1, p=0.036) and a diagnosis of hypertension (β=0.46, p=0.0093) were significant predictors of increased WMH volume as a percentage of ICV with correction for age, stroke subtype and smoking status (Table 2 and Figure 3). Repetition of the analysis with replacement of PP and MAP with diastolic and systolic BP showed that systolic but not diastolic BP was positively associated with transformed %WMH (β=0.0079 mmHg-1, p=0.040). Salt intake score was also positively associated with WMH volume (β=0.14, p=0.021; Figure 3); further analyses using the separate scores for cooking and table salt usage were consistent with this finding (β=-0.11/-0.067; p=0.020/0.18 for cooking/table salt – note that the coefficient sign change is expected, since the combined score was inverted). Regression analysis of brain tissue volume (mean: 71±5% of ICV) with the same covariates revealed a positive association between plasma sodium concentration and %BTV corresponding to an absolute increase in brain tissue volume of 2% ICV per 10 mmol/L sodium (p=0.019). Age was the most significant factor in the analyses of both %WMH and %BTV (p<0.0001).
Diffusion tensor MRI
DT-MRI data were obtained in 262 subjects (DT-MRI data for two subjects were rejected due to failure of the non-linear image registration). MD was distributed with mean values of 801±52 and 787±32 × 10-6 mm2s-1 in subcortical GM and NAWM respectively, with corresponding FA of 0.234±0.021 and 0.256±0.022. The influence of blood pressure, added salt intake and plasma sodium concentration on these variables was modelled with correction for smoking, stroke subtype and age, as well as normalised WMH volume to account for SVD severity (Table 3). Plasma sodium concentration was negatively associated with MD in NAWM (β=-1.2×10-6 mm2s-1mmol-1L; p=0.011) and FA in subcortical GM (β=-0.9×10-3 mmol-1L; p=0.021). Salt intake score was negatively associated with FA in subcortical GM (β=-3.4×10-3 mmol-1L; p=0.0012); additional analyses using the separate scores for salt usage during cooking and at the table were consistent with this finding (β=2.0/2.5; p=0.016/0.0052 for cooking/table salt). In WM, there were corresponding trends for reduced FA with increasing salt score (β=-1.3×10-3; p=0.19) and lower plasma sodium (β=0.62×10-3 mmol-1L; p=0.090) but these were not significant at the two-tailed 5% type 1 error level.
DCE-MRI
Of the 264 patients recruited, 56 did not undergo DCE-MRI at one-month follow-up due to decline in renal function (3), being too unwell (7), lack of venous access (4) and  declining to have the scan (42). Of the 208 patients that underwent DCE-MRI, data suitable for analysis was obtained in 201 (data for seven subjects were rejected due to “tissueing” of contrast, technical faults during the scan or unacceptable data quality caused by patient movement). DCE-MRI parameters were modelled using the same covariates as for DT-MRI data (Table 4). Plasma sodium concentration was positively associated with nAUC in NAWM (β=0.18×10-3; p=0.019) but blood pressure, hypertension and salt intake score were not significant predictors. The most significant co-variate in these analyses was age, which was negatively associated with nAUC in both NAWM and subcortical GM (p<0.0001).
Discussion
Our finding that arterial blood pressure is associated with increased white matter hyperintensity volume is broadly consistent with the results of previous studies  ADDIN EN.CITE , ,  and with the hypothesis that sustained pressure elevation and pressure fluctuations in the small cerebral vessels result in microvascular damage. ADDIN EN.CITE 22 The independent association with clinical diagnosis of hypertension, additional to that of BP, likely reflects the historical effect of blood pressure elevation on vasculature and end organs in addition to that at the time of the study.  Others have shown that WMH volume is also predicted by increased large artery stiffness, which may be one cause of increased pressure fluctuations in the small cerebral vessels. ADDIN EN.CITE , 
A novel finding of this study is that routinely adding more salt to food, which likely increases overall dietary salt intake in addition to the amounts of salt already present in food, is associated with greater WMH volume. There was also a highly significant negative association between the salt intake score and fractional anisotropy in normal-appearing subcortical GM, suggestive of “previsible” reduced tissue integrity. ADDIN EN.CITE 25 The interactions between salt intake, blood pressure and cerebrovascular disease are not fully understood: it is widely accepted that sodium intake increases blood pressure ADDIN EN.CITE 26 and that hypertension leads to cardiovascular disease including stroke ADDIN EN.CITE ,  and there is indirect evidence to support the beneficial effects of reducing the salt intake on the incidence of cardiovascular disease ADDIN EN.CITE , . Furthermore, epidemiological studies indicate that salt intake is associated with increased risk of stroke and cardiovascular disease independently of blood pressure. ADDIN EN.CITE , ,  Our findings, which are corrected for blood pressure (both pulse pressure and mean arterial pressure), hypertension and age (as much as one can), suggest this might also be the case in cerebral small vessel disease. Studies in the literature addressing the role of sodium in SVD are lacking and the pathophysiological mechanism of any harm is unclear. A possible direct effect of salt on the endothelium, in addition to any effect via elevated BP, might account for the increased stroke risk due to salt beyond that accounted for by hypertension alone: for example, salt-sensitive (versus salt-resistant) hypertension is associated with peripheral endothelial dysfunction ADDIN EN.CITE 32 which, if also present in the brain, might account for the dynamic cerebral and systemic endothelial dysfunction seen in several studies of SVD HYPERLINK \l "_ENREF_33" \o "Stevenson, 2010 #34"  ADDIN EN.CITE <EndNote><Cite><Author>Stevenson</Author><Year>2010</Year><RecNum>46</RecNum><DisplayText><style face="superscript">33</style></DisplayText><record><rec-number>34</rec-number><foreign-keys><key app="EN" db-id="tf0fsv95t5tvw8eefx35t2d8as2wtfwp20ts" timestamp="1425399772">34</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Stevenson, S. F.</author><author>Doubal, F. N.</author><author>Shuler, K.</author><author>Wardlaw, J. M.</author></authors></contributors><auth-address>SINAPSE Collaboration, SFC Brain Imaging Research Centre, Division of Clinical Neurosciences, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU, UK.</auth-address><titles><title>A systematic review of dynamic cerebral and peripheral endothelial function in lacunar stroke versus controls</title><secondary-title>Stroke</secondary-title><alt-title>Stroke</alt-title></titles><periodical><full-title>Stroke</full-title><abbr-1>Stroke</abbr-1></periodical><alt-periodical><full-title>Stroke</full-title><abbr-1>Stroke</abbr-1></alt-periodical><pages>e434-42</pages><volume>41</volume><number>6</number><keywords><keyword>Brain/blood supply/pathology</keyword><keyword>Brain Ischemia/etiology/*metabolism/pathology</keyword><keyword>*Cerebrovascular Circulation</keyword><keyword>Endothelium/*metabolism/pathology</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Risk Factors</keyword><keyword>Stroke/etiology/*metabolism/pathology</keyword></keywords><dates><year>2010</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1524-4628 (Electronic)&#xD;0039-2499 (Linking)</isbn><accession-num>20395619</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/20395619</url></related-urls></urls><electronic-resource-num>10.1161/STROKEAHA.109.569855</electronic-resource-num></record></Cite></EndNote>33 and the increased level of WMH seen here. However, although the linear model used here fitted our data well, the significance of salt intake score as an independent predictor of WMH could also be influenced by complex non-linear interactions between salt intake, blood pressure and vascular disease, which become steeper with advancing age, in hypertensives and high salt intake ADDIN EN.CITE 28.
In contrast to dietary sodium consumption, plasma sodium concentration did not predict WMH volume but was associated with brain tissue volume, corresponding to an increase of 2% of ICV per 10 mmol/L sodium. Lower plasma sodium was also associated with increased MD in NAWM and increased FA in subcortical GM. The explanations for these associations are unknown and should be explored in future studies. Changes in brain volume may occur following acute changes in osmolality, but are thought to be temporary and rapidly reversed following changes in solute balance. HYPERLINK \l "_ENREF_34" \o "Verbalis, 2010 #35"  ADDIN EN.CITE <EndNote><Cite><Author>Verbalis</Author><Year>2010</Year><RecNum>42</RecNum><DisplayText><style face="superscript">34</style></DisplayText><record><rec-number>35</rec-number><foreign-keys><key app="EN" db-id="tf0fsv95t5tvw8eefx35t2d8as2wtfwp20ts" timestamp="1425399772">35</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Verbalis, J. G.</author></authors></contributors><auth-address>Department of Medicine, 232 Building D, Georgetown University Medical Center, 4000 Reservoir Road NW, Washington, DC 20007, USA. verbalis@georgetown.edu</auth-address><titles><title>Brain volume regulation in response to changes in osmolality</title><secondary-title>Neuroscience</secondary-title><alt-title>Neuroscience</alt-title></titles><periodical><full-title>Neuroscience</full-title><abbr-1>Neuroscience</abbr-1></periodical><alt-periodical><full-title>Neuroscience</full-title><abbr-1>Neuroscience</abbr-1></alt-periodical><pages>862-70</pages><volume>168</volume><number>4</number><keywords><keyword>Animals</keyword><keyword>Aquaporins/*metabolism</keyword><keyword>Body Water/metabolism</keyword><keyword>Brain/anatomy &amp; histology/*metabolism</keyword><keyword>Humans</keyword><keyword>Organ Size</keyword><keyword>Osmotic Pressure</keyword></keywords><dates><year>2010</year><pub-dates><date>Jul 28</date></pub-dates></dates><isbn>1873-7544 (Electronic)&#xD;0306-4522 (Linking)</isbn><accession-num>20417691</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/20417691</url></related-urls></urls><electronic-resource-num>10.1016/j.neuroscience.2010.03.042</electronic-resource-num></record></Cite></EndNote>34 Furthermore, none of our participants were either hypernatraemic (defined as [Na]>146 mmol/L) or severely hyponatraemic ([Na]<125 mmol/L), though 13% were mild to moderately hyponatraemic (125≤[Na]≤135 mmol/L). These findings may reflect transient changes related to hydration state, diet, time of day or other factors. Most of our patients were managed as outpatients, not being ill enough to require hospital admission, and were mobile, cognitively competent outpatients with no clinical evidence of dehydration. However, plasma sodium was also associated with contrast uptake at DCE-MRI measured one month later, corresponding to a relative increase in nAUC in NAWM of 20% per 10 mmol/L sodium; this suggests that part of the association with brain volume may be accounted for by differences in blood volume. Age was a strong negative predictor of nAUC in GM and NAWM, consistent with literature reports of a reduction in the cerebral blood supply with age. ADDIN EN.CITE 35 We note that, although contrast uptake in normal-appearing brain tissue is likely to be primarily intravascular, increased blood-brain barrier permeability in patients with SVD may result in an extracellular contribution to the nAUC particularly at older ages; HYPERLINK \l "_ENREF_36" \o "Farrall, 2009 #37"  ADDIN EN.CITE <EndNote><Cite><Author>Farrall</Author><Year>2009</Year><RecNum>39</RecNum><DisplayText><style face="superscript">36</style></DisplayText><record><rec-number>37</rec-number><foreign-keys><key app="EN" db-id="tf0fsv95t5tvw8eefx35t2d8as2wtfwp20ts" timestamp="1425399773">37</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Farrall, A. J.</author><author>Wardlaw, J. M.</author></authors></contributors><auth-address>Division of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh, UK. Andrew.Farrall@ed.ac.uk</auth-address><titles><title>Blood-brain barrier: ageing and microvascular disease--systematic review and meta-analysis</title><secondary-title>Neurobiol Aging</secondary-title><alt-title>Neurobiol Aging</alt-title></titles><periodical><full-title>Neurobiol Aging</full-title><abbr-1>Neurobiol Aging</abbr-1></periodical><alt-periodical><full-title>Neurobiol Aging</full-title><abbr-1>Neurobiol Aging</abbr-1></alt-periodical><pages>337-52</pages><volume>30</volume><number>3</number><keywords><keyword>*Aging/physiology</keyword><keyword>Alzheimer Disease/metabolism/physiopathology</keyword><keyword>Animals</keyword><keyword>Blood-Brain Barrier/*metabolism/*physiopathology</keyword><keyword>Capillary Permeability/physiology</keyword><keyword>Cerebrovascular Circulation/physiology</keyword><keyword>Cerebrovascular Disorders/metabolism/physiopathology</keyword><keyword>Dementia, Vascular/metabolism/physiopathology</keyword><keyword>Humans</keyword><keyword>Microvessels/*metabolism/*physiopathology</keyword></keywords><dates><year>2009</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1558-1497 (Electronic)&#xD;0197-4580 (Linking)</isbn><accession-num>17869382</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/17869382</url></related-urls></urls><electronic-resource-num>10.1016/j.neurobiolaging.2007.07.015</electronic-resource-num></record></Cite></EndNote>36 indeed, the positive association of nAUC with WMH volume may indicate such a contribution. Quantitative assessment of contrast extravasation in this patient group will be considered in future work.
All analyses presented in this work were corrected for whether subjects were smokers. In line with the previous literature, smokers had both greater WMH volume ADDIN EN.CITE 37 and lower brain volume ADDIN EN.CITE 38 corresponding to a total brain volume difference of approximately 1% of intracranial volume.
Our results concerning added dietary salt are limited by the qualitative and self-reported nature of these data. The index, based on a simple questionnaire, was designed for use in our clinical setting and did not attempt to assess total salt intake, an acknowledged complex task due to problems with accurate recall, and by the highly variable amounts of salt present in food or added by manufacturers during processing. However, our index may better reflect salt appetite and long-term exposure to salt. There is no gold-standard way to assess the salt intake of these patients retrospectively, and even the validity of a 24h urine collection, which is not practical in this cohort, has been questioned HYPERLINK \l "_ENREF_39" \o "Titze, 2014 #41"  ADDIN EN.CITE <EndNote><Cite><Author>Titze</Author><Year>2014</Year><RecNum>2351</RecNum><DisplayText><style face="superscript">39</style></DisplayText><record><rec-number>41</rec-number><foreign-keys><key app="EN" db-id="tf0fsv95t5tvw8eefx35t2d8as2wtfwp20ts" timestamp="1425399774">41</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Titze,Jens</author><author>Dahlmann,Anke</author><author>Lerchl,Kathrin</author><author>Kopp,Christoph</author><author>Rakova,Natalia</author><author>Schroder,Agnes</author><author>Luft,Friedrich C.</author></authors></contributors><titles><title>Spooky sodium balance</title><secondary-title>Kidney International</secondary-title></titles><periodical><full-title>Kidney International</full-title></periodical><pages>759-767</pages><volume>85</volume><reprint-edition>Not in File</reprint-edition><keywords><keyword>Aldosterone</keyword><keyword>blood pressure</keyword><keyword>cortisol</keyword><keyword>lymph capillaries</keyword><keyword>NFAT5</keyword><keyword>rhythms</keyword><keyword>Sodium</keyword></keywords><dates><year>2014</year><pub-dates><date>4/2014 print</date></pub-dates></dates><label>2427</label><urls><related-urls><url>http://dx.doi.org/10.1038/ki.2013.367</url></related-urls></urls></record></Cite></EndNote>39. More complex questionnaires given by a dietician can provide a measure of intake but also depend on self-report and would not have been appropriate with this cohort of patients. A disadvantage of both detailed dietary questionnaires and biochemical tests is that they provide a snapshot of salt consumption, which may not reflect long-term exposure and habits, particularly during recovery from a stroke where intake may have been influenced by the recent stroke and lifestyle advice. Future work might focus on a more quantitative assessment of salt intake in patients presenting with mild stroke. Despite these reservations, our index correlated well with WMH volume and the trend was preserved when assessed using our two separate salt scores.
A second limitation is that our blood tests, while quantitative, measured plasma sodium concentration at a single point in time contemporaneous with measurement of WMH volume, %BTV, FA and MD but not nAUC. As plasma sodium concentration shows strong individuality, it is unlikely to vary much unless the patient is over or under hydrated  HYPERLINK \l "_ENREF_40" \o "Zhang, 2014 #42"  ADDIN EN.CITE <EndNote><Cite><Author>Zhang</Author><Year>2014</Year><RecNum>2538</RecNum><DisplayText><style face="superscript">40</style></DisplayText><record><rec-number>42</rec-number><foreign-keys><key app="EN" db-id="tf0fsv95t5tvw8eefx35t2d8as2wtfwp20ts" timestamp="1425399774">42</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhang, Zheng</author><author>Duckart, Jonathan</author><author>Slatore, Christopher G.</author><author>Fu, Yi</author><author>Petrik, Amanda F.</author><author>Thorp, Micah L.</author><author>Cohen, David M.</author></authors></contributors><titles><title>Individuality of the plasma sodium concentration</title><secondary-title>American Journal of Physiology - Renal Physiology</secondary-title></titles><periodical><full-title>American Journal of Physiology - Renal Physiology</full-title></periodical><pages>F1534-F1543</pages><volume>306</volume><number>12</number><dates><year>2014</year></dates><label>2602</label><work-type>10.1152/ajprenal.00585.2013</work-type><urls><related-urls><url>http://ajprenal.physiology.org/content/306/12/F1534.abstract</url></related-urls></urls></record></Cite></EndNote>40. It should also be noted that the plasma sodium concentration can be influenced by kidney function, glucose level and medication (13.3% of patients had reduced kidney function (eGFR<60 ml/min/1.73m2) and 19.3% of patients took the diuretic medications Bendrofluimethiazide or Furosemide). However, correcting for these potential confounds made little difference to our results. Finally, we note that the age range of participants in this study was wide (34-96 years) and findings may be confounded by age-related effects not fully eliminated by the model; it is therefore desirable to replicate the findings in a larger study or in a sample with narrower age range.
In conclusion, arterial pulse pressure and diagnosis of hypertension predict WMH volume in patients with mild stroke. Added dietary salt intake was also independently associated with WMH. Plasma sodium concentration, while not associated with WMH volume, was a significant predictor of brain tissue volume and of gadolinium contrast agent uptake in NAWM.
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Titles and legends to figures

Figure 1: Flow chart showing recruitment to the Mild Stroke Study 2.
Figure 2: Representative MRI data and tissue segmentation. A) FLAIR image, B) Tissue masks superimposed on FLAIR image, C) Fractional anisotropy map, D) Contrast agent concentration curves obtained from DCE-MRI; y-axes scales for the sagittal sinus plasma concentration and normal-appearing tissue concentration curves are shown on the left and right respectively.
Figure 3: Relationship between white matter hyperintensity volume and pulse pressure, diagnosis of hypertension and salt intake score. The association between WMH volume and pulse pressure (Spearman’s R=0.26, p<0.001) survived correction for age and all other factors listed in Table 2. 



Table 1: Descriptive statistics for demographic, clinical and imaging variables including DT-MRI and DCE-MRI parameters in normal-appearing white matter and subcortical grey matter.

Parameter	N	Mean (SD)
Age (years)	264	66.9 (11.8)
Sex (% female)	264	42
Stroke subtype (% lacunar)	264	45
Hypertension (%)	264	72
Smokera (%)	262	39
Diabetes (%)	264	11
Pulse pressure (mmHg)	264	63 (20)
Mean arterial pressure (mmHg)	264	103 (15)
Salt intake score	250	2.7 (1.3)
Plasma sodium concentration (mmol/L)	260	139 (3)
Structural MRI	%WMH (%)		264	1.5 (1.6)
	%BTV (%)		264	71 (5)
DT-MRI	MD (10-6 mm2s-1)	GM	262	801 (52)
		NAWM	262	787 (32)
	FA	GM	262	0.234 (0.021)
		NAWM	262	0.256 (0.022)
DCE-MRI	nAUC (10-3)	GM	201	16.8 (4.3)
		NAWM	201	9.9 (3.7)
a Currently smoking or had given up within the previous 12 months.



Table 2: Multiple linear regression analysis of %WMH and %BTV.
	ln(0.005+%WMH) 	%BTV
	β (95% CI)	p	β (95% CI)	p
PP (mmHg)	0.0092 (0.00059, 0.018)	0.036	-0.022 (-0.054, 0.011)	0.20
MAP (mmHg)	-0.0037 (-0.015, 0.0073)	0.51	0.013 (-0.029, 0.055)	0.55
Hypertension	0.46 (0.11, 0.81)	0.0093	-0.68 (-2.0, 0.65)	0.31
Salt intake score	0.14 (0.021, 0.25)	0.021	0.26 (-0.19, 0.70)	0.26
Plasma sodium (mmol/L)	-0.029 (-0.072, 0.014)	0.18	0.20 (0.033, 0.36)	0.019
Smoking	0.31 (-0.0033, 0.63)	0.052	-1.2 (-2.4, 0.039)	0.058
Stroke subtype (cortical=0, lacunar=1)	0.27 (-0.023, 0.57)	0.070	-0.40 (-1.5, 0.73)	0.49
Age (years)	0.053 (0.039, 0.067)	<0.0001	-0.25 (-0.30, -0.20)	<0.0001




Table 3: Multiple linear regression analysis of DT-MRI measurements in normal-appearing white matter and subcortical grey matter.
	ln(-700+MDGM[10-6 mm2s-1])	MDNAWM(10-6 mm2s-1)	FAGM(10-3)	FANAWM(10-3)
	β (95% CI)	p	β (95% CI)	p	β (95% CI)	p	β (95% CI)	p
PP (mmHg)	0.00079
(-0.0018, 0.0033)	0.54	0.16
(-0.021, 0.34)	0.083	0.056
(-0.095, 0.21)	0.47	-0.030
(-0.17, 0.11)	0.68
MAP (mmHg)	0.0020
(-0.0013, 0.0052)	0.24	-0.14
(-0.38, 0.090)	0.23	-0.094
(-0.29, 0.10)	0.34	-0.041
(-0.22, 0.14)	0.66
Hypertension	0.046
(-0.058, 0.15)	0.39	0.64
(-6.7, 8.0)	0.86	-3.7
(-9.8, 2.4)	0.23	-2.1
(-7.9, 3.7)	0.48
Salt intake score	0.013
(-0.022, 0.048)	0.46	0.54
(-1.9, 3.0)	0.66	-3.4
(-5.5, -1.4)	0.0012	-1.3
(-3.2, 0.63)	0.19
Plasma sodium(mmol/L)	-0.0027
(-0.015, 0.010)	0.68	-1.2
(-2.1, -0.28)	0.011	-0.90
(-1.7, -0.14)	0.021	0.62
(-0.096, 1.3)	0.090
Smoking	0.016
(-0.078, 0.11)	0.74	3.8
(-2.9, 10.)	0.27	2.0
(-3.6, 7.6)	0.48	-1.5
(-6.8, 3.7)	0.57
Stroke subtype(cortical=0, lacunar=1)	0.096
(0.0079, 0.18)	0.033	0.60
(-5.7, 6.9)	0.85	-9.8
(-15., -4.5)	0.00029	-0.047
(-5.0, 4.9)	0.98
Age (years)	0.014
(0.0095, 0.018)	<0.0001	1.2
(0.89, 1.5)	<0.0001	0.088
(-0.18, 0.35)	0.51	-0.53
(-0.77, -0.28)	<0.0001
%WMH (%)	0.15
(0.12, 0.18)	<0.0001	4.9
(2.8, 7.0)	<0.0001	-2.3
(-4.0, -0.56)	0.0097	-4.5
(-6.1, -2.9)	<0.0001




Table 4: Multiple linear regression analysis of DCE-MRI measurements in normal-appearing white matter and subcortical grey matter.
	nAUCGM
(10-3)	nAUCNAWM
(10-3)
	β (95% CI)	p	β (95% CI)	p
PP (mmHg)	0.016 (-0.018, 0.050)	0.34	0.0068 (-0.022, 0.036)	0.65
MAP (mmHg)	-0.0095 (-0.054, 0.035)	0.67	-0.0069 (-0.045, 0.032)	0.72
Hypertension	-0.44 (-1.9, 1.0)	0.55	-0.32 (-1.6, 0.93)	0.62
Salt intake score	0.14 (-0.33, 0.61)	0.56	0.015 (-0.39, 0.42)	0.94
Plasma sodium (mmol/L)	0.010 (-0.16, 0.18)	0.91	0.18 (0.030, 0.33)	0.019
Smoking	-0.36 (-1.7, 0.96)	0.59	-1.2 (-2.3, -0.034)	0.044
Stroke subtype (cortical=0, lacunar=1)	-0.028 (-1.2, 1.2)	0.96	-0.39 (-1.4, 0.63)	0.45
Age (years)	-0.18 (-0.24, -0.11)	<0.0001	-0.14 (-0.19, -0.082)	<0.0001
%WMH (%)	0.40 (0.0018, 0.80)	0.049	0.40 (0.053, 0.74)	0.024
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